Cav-1 (Caveolin-1) and Arterial Remodeling in Adult Moyamoya Disease

Background and Purpose Moyamoya disease (MMD) is a unique cerebrovascular occlusive disease characterized by progressive stenosis and negative remodeling of the distal internal carotid artery (ICA). We hypothesized that cav-1 (caveolin-1)a protein that controls the regulation of endothelial vesicular trafficking and signal transductionis associated with negative remodeling in MMD. Methods We prospectively recruited 77 consecutive patients with MMD diagnosed via conventional angiography. Seventeen patients with intracranial atherosclerotic stroke and no RNF213 mutation served as controls. The outer distal ICA diameters were examined using high-resolution magnetic resonance imaging. We evaluated whether the degree of negative remodeling in the patients with MMD was associated with RNF213 polymorphism, cav-1 levels, or various clinical and vascular risk factors. We also investigated whether the derived factor was associated with negative remodeling at the cellular level using the tube formation and apoptosis assays. Results The serum cav-1 level was lower in the patients with MMD than in the controls (0.470.29 versus 0.86 +/- 0.68 ng/mL; P=0.034). The mean ICA diameter was 2.48 +/- 0.98 mm for the 126 affected distal ICAs in patients with MMD and 3.84 +/- 0.42 mm for the asymptomatic ICAs in the controls (P<0.001). After adjusting for confounders, cav-1 levels (coefficient, 1.018; P<0.001) were independently associated with the distal ICA diameter in patients with MMD. In vitro analysis showed that cav-1 downregulation suppressed angiogenesis in the endothelial cells and induced apoptosis in the smooth muscle cells. Conclusions Our findings suggest that cav-1 may play a major role in negative arterial remodeling in MMD.